Sanofi teams up with Medtronic in diabetes
This article was originally published in Scrip
Executive Summary
Parisian big pharma Sanofi and US medical device giant Medtronic are planning to team up under an "open innovation" alliance to develop diabetes drug-device combinations focused on improving patient adherence to medicines.
You may also be interested in...
Accessing Venture Debt From The EIB
Tips from Gergely Krajcsi, senior investment officer at the European Investment Bank, on how biotechs can access loans for faster growth.
In Vivo's 2024 Rising Leaders At A Glance
Top 30 leaders: see the list of industry influencers highlighted in the fifth edition of In Vivo's Rising Leaders series.
In Vivo’s 2024 Rising Leaders
The fifth annual listing of In Vivo’s Rising Leaders includes entrepreneurs and innovators from across the world who represent the next wave of creativity in health care.